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Retained haemothorax is a common sequela of traumatic haemothorax and refers to blood that cannot be drained from the pleural
cavity. We report a case of trapped lung secondary to retained haemothorax in a patient who sustained a penetrating chest injury.
Initial chest computed tomography (CT) showed a large haemothorax that was managed with an intercostal drain insertion (ICD).
Repeat chest CT and thoracic ultrasonography performed after ICD removal showed an organized pleural space resembling
haematoma. ICD was reinserted with administration of intrapleural fibrinolytic therapy (IPFT). Subsequent chest CT showed
the development of a pleural rind and trapped lung. A second ICD was inserted, and further IPFT were administered together
with aggressive negative pressure suction. Haemoglobin remained stable. The patient made a full recovery and imaging
performed two weeks later showed minor blunting of the costophrenic angle. This case highlights the feasibility and safety of
IPFT in the management of trapped lung associated with traumatic retained haemothorax as an alternative to surgery.
1. Introduction
Haemothorax is an accumulation of blood in the pleural space
and is often the result of trauma to the chest. Retained haemo-
thorax refers to blood that cannot be drained from the pleural
cavity and is associated with complications including empyema
and fibrothorax. Traditionally, haemothorax is managed surgi-
cally with tube thoracostomy drainage and video-assisted thora-
coscopy surgery. Despite the rise in the utilisation of intrapleural
fibrinolytic therapy in parapneumonic effusions and empyema,
its role in haemothorax remains unclear. We present a case of
trapped lung associatedwith acute traumatic haemothorax com-
plicated by retained haemothorax that was successfullymanaged
with intrapleural fibrinolytic therapy, highlighting the feasibility
and safety of this management strategy.
2. Case Report
A 19-year-old male was transferred from a local district hospi-
tal to our centre for the management of traumatic chest inju-
ries. The patient had been involved in an altercation and
sustained three knife stab injuries. Two of these were superfi-
cial and affected the right upper and lower chest wall. The
third was a deep penetrating injury to the left hemithorax.
Chest computed tomography (CT) performed at the local
district hospital showed a large volume left sided haemotho-
rax which was managed with a 24Fr intercostal drain (ICD).
As a temporizing measure, the penetrating injury was packed
with a ribbon gauze, and after the patient was stabilized, he
was transferred to our regional level 1 trauma centre. The
patient received 9 units of packed red blood cells, 2 units of
fresh frozen plasma, and 2 units of platelets prior to transfer.
On examination, heart rate was regular at 93 beats/min,
blood pressure of 106/55mmHg, respiratory rate of 34
breaths/min, and oxygen saturation of 97% on 2L/min sup-
plemental oxygen. The ICD had drained 1800mL of blood,
and the blood test showed a haemoglobin of 140 g/L (normal
135-172 g/L), platelet of 263 × 109 (150-370 × 109), pro-
thrombin time of 13.4 s (10.8-13.3 s), activated partial throm-
boplastin time of 24.7 s (28.2-36.6 s), and fibrinogen of 2.62
g/L (1.46-3.33 g/L). Renal and liver function tests were within
normal limits. Chest CT demonstrated a slight reduction in
the size of the left sided haemothorax and no evidence of
active bleeding (Figure 1(a)). The ICD was up sized to a
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32Fr to promote clot removal, and prophylactic intravenous
co-amoxiclav was administered. No further blood products
were required, and the patient was managed conservatively.
The ICD was removed three days later after 24 hours of
minimal output and chest X-ray (CXR) showing a small vol-
ume of residual effusion. A day later, the patient developed a
new fever and rising inflammatory markers. A repeat chest
CT revealed a moderate volume haemothorax (Figure 1(b)).
Thoracic ultrasound (TUS) identified an organized pleural
space resembling haematoma with minimal pleural effusion.
Given concerns over an evolving empyema in a retained hae-
mothorax, co-amoxiclav was changed to piperacillin/tazobac-
tam, and a 12Fr ICD was inserted under ultrasound guidance
into the complex pleural effusion. This initially drained 300
mL of red-brown fluid (degraded haemoglobin) followed by a
further 800mL after a single dose of 10mg intrapleural alte-
plase diluted in 10mL of normal saline. CXR the following
day showed an increased in the size of the pleural effusion.
TUS however demonstrated a finely organized collection with
minimal free flowing fluid. Together with a stable haemoglobin
andminimal ICD output, it was felt that the changes weremore
likely due to an evolving empyema than recurrent pleural
haemorrhage. A further two doses of intrapleural fibrinolytic
therapy (10mg alteplase and 5mg dornase alfa) were adminis-
tered resulting in a further drainage of 2000mL of red-brown
fluid. Subsequent chest CT showed a small residual basal col-
lection and a thin pleural rind causing tapped lung
(Figure 1(c)). Meanwhile, pleural fluid returned as an exudate
with no evidence of infection on pH, microscopy, or culture.
As the patient wanted to avoid surgery, an attempt to clear
the pleural space and breakdown the pleural rind was made
by inserting a second ICD into the basal collection,
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Figure 1: Serial axial chest computed tomography (CT) demonstrating reduction in size of the left sided haemothorax over time. Images on
the left and right represent CT slices taken at the level of the carina and the lung base, respectively. Day 0 refers to day of admission.
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administering a further dose of 10mg intrapleural alteplase,
and placing the ICD on 4kPa wall suction. Chest CT per-
formed four days later showed significant improvement with
minimal residual fluid and near-complete reexpansion of the
trapped lung (Figure 1(d)). Both ICDs were removed, and the
patient was discharged the next day. Haemoglobin remained
stable throughout the admission, and no blood transfusions
were required (Figure 2). On follow-up two weeks later, the
patient hadmade a full recovery with CXR demonstratingmin-
imal blunting of the left costophrenic angle (Figure 3).
3. Discussion
Haemothorax is defined as a collection of blood within the
pleural space and is often the result of sharp or blunt trauma
to the chest. The exact incidence of haemothorax is unclear
and is estimated to be around 300,000 cases annually in the
United States [1]. The initial management of haemothorax
includes prompt resuscitation and drainage, usually with a
large calibre (>28Fr) ICD as this allows some clots to be evac-
uated [2]. Drainage allows expansion of the underlying lung
and permits accurate assessment of the rate of blood loss, a
key factor in the deciding if early surgical intervention is
required [3]. Clotted or retained haemothorax is a known
complication of haemothorax and occurs in up to 20% of
traumatic haemothorax [4]. Left untreated, retained haemo-
thorax may resorb over time, become infected, or progress
to fibrothorax. Studies suggest that roughly one in four
retained haemothorax evolves into empyema and that evi-
dence of angiofibroblastic proliferation, the precursor to
fibrothorax, is present by day 7, as seen in this case [5]. For
these reasons, it is critical that retained haemothorax be evac-
uated promptly.
Video-assisted thoracoscopy surgery (VATS) is the treat-
ment of choice for retained haemothorax however requires
patients to be able to tolerate general anaesthesia and single
lung ventilation [6]. Furthermore, up to 20% of VATS proce-
dures require conversion to thoracotomy, increasing postop-
erative morbidity and the risk of neuropathic pain [7].
Intrapleural fibrinolytic therapy (IPFT) has been shown to
be effective in the management of complex parapneumonic
effusions and empyema, decreasing the need for surgical
intervention [8]. Its role in retained haemothorax, however,
remains unclear with studies reporting mixed results when
compared to VATS [9, 10].
The patient in our case had trapped lung secondary to
retained haemothorax in the context of penetrating chest
wall trauma. Although there were initial concerns over super-
imposed empyema, this was subsequently thought to be
unlikely based on the appearance and analysis of the pleural
fluid. Given his age and lack of comorbidities, our patient
would be an ideal candidate for VATS. However, due to his
personal preference of wanting to avoid surgery, IPFT was
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Figure 2: Haemoglobin trend throughout admission. The red arrow indicates administration of intrapleural fibrinolysis. The green arrow
indicates haemoglobin on follow-up.
Figure 3: Chest X-ray taken at 2 weeks postdischarge showing clear
lung fields and minimal blunting of the left costophrenic angle.
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utilised as the next best management strategy with huge suc-
cess. IPFT is unlikely to have any effect on chronic pleural
peel as these are mainly composed of collagen in contrast to
the high fibrin content in its early phases of development
[3]. We hypothesize that the early and aggressive use of IPFT
in our case contributed to the success in breaking down the
pleural rind and facilitating lung reexpansion.
Bleeding post IPFT is a feared complication that fortu-
nately rarely occurs [11]. The use of IPFT in individuals with
high bleeding risk (e.g., acute bleed, dysregulated clotting,
and recent major surgery) has not been well studied, and
thus, the risk remains uncertain. In our case of acute trau-
matic haemothorax, we did not observe any decline in hae-
moglobin associated with the repeated administration of
IPFT.
In summary, this case highlights the feasibility of using
IPFT in the management of trapped lung associated with






IPFT: Intrapleural fibrinolytic therapy
TUS: Thoracic ultrasound
VATS: Video-assisted thoracoscopy surgery.
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